{"doi":"10.3803/enm.2022.605","title":"DPP-4 Inhibitor in Type 2 Diabetes Mellitus Patient with Non-Alcoholic Fatty Liver Disease: Achieving Two Goals at Once?","abstract":null,"journal":"Endocrinology and Metabolism","year":2022,"id":652402,"datarank":0.41588830833596724,"base_score":2.772588722239781,"endowment":2.772588722239781,"self_citation_contribution":0.41588830833596724,"citation_network_contribution":0.0,"self_endowment_contribution":0.41588830833596724,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":15,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1099403,"name":"Ji Cheol Bae","orcid":"0000-0002-4763-5797","position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"DPP-4 Inhibitor in Type 2 Diabetes Mellitus Patient with Non-Alcoholic Fatty Liver Disease: Achieving Two Goals at Once?","abstract":null,"is_dataset_classified":null,"base_score":2.772588722239781,"endowment":2.772588722239781,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"36604957","pmcid":"PMC9816515","openalex_id":"https://openalex.org/W4312197462","authors":[],"funders":[],"total_grants":0,"fwci":2.0542,"citation_percentile":0.87590778,"influential_citations":0,"citation_trend":[{"year":2023,"count":3},{"year":2024,"count":5},{"year":2025,"count":6},{"year":2026,"count":1}],"oa_status":"gold","license":"cc-by-nc","oa_locations":[{"url":"https://www.e-enm.org/upload/pdf/enm-2022-605.pdf","host_type":"journal"},{"url":"https://www.e-enm.org/upload/pdf/enm-2022-605.pdf","host_type":"publisher"},{"url":"http://e-enm.org/upload/pdf/enm-2022-605.pdf","host_type":"publisher"},{"url":"http://e-enm.org/journal/view.php?doi=10.3803/EnM.2022.605","host_type":"publisher"},{"url":"https://doi.org/10.3803/enm.2022.605","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/36604957","host_type":"repository"},{"url":"https://doaj.org/article/9a4f64b156d946b3ac1040bd4ed0f7e6","host_type":"repository"},{"url":"https://www.ncbi.nlm.nih.gov/pmc/articles/9816515","host_type":"repository"},{"url":"https://europepmc.org/articles/PMC9816515","host_type":"Europe_PMC"},{"url":"https://europepmc.org/articles/PMC9816515?pdf=render","host_type":"Europe_PMC"}],"fields_of_study":["Liver Disease Diagnosis and Treatment","Diabetes Treatment and Management","Diet, Metabolism, and Disease","Humans","Diabetes Mellitus, Type 2","Dipeptidyl-Peptidase IV Inhibitors","Hypoglycemic Agents","Non-alcoholic Fatty Liver Disease"],"mesh_terms":["Diabetes Mellitus, Type 2","Humans","Hypoglycemic Agents","Dipeptidyl-Peptidase IV Inhibitors","Non-alcoholic Fatty Liver Disease"],"keywords":["Medicine","Fatty liver","Disease","Type 2 Diabetes Mellitus","Type 2 diabetes","Diabetes mellitus","Alcoholic liver disease","Internal medicine","Gastroenterology","Endocrinology","Cirrhosis"],"sdg_mappings":[],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-08-10T13:35:00.986493Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}